B7-H4 Pathway in Islet Transplantation and β-Cell Replacement Therapies
Type 1 diabetes (T1D) is a chronic autoimmune disease and characterized by absolute insulin deficiency. β-cell replacement by islet cell transplantation has been established as a feasible treatment option for T1D. The two main obstacles after islet transplantation are alloreactive T-cell-mediated gr...
Saved in:
Main Authors: | Xiaojie Wang, Jianqiang Hao, Daniel L. Metzger, Ziliang Ao, Mark Meloche, C. Bruce Verchere, Lieping Chen, Dawei Ou, Alice Mui, Garth L. Warnock |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Journal of Transplantation |
Online Access: | http://dx.doi.org/10.1155/2011/418902 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Generation of Transplantable Beta Cells for Patient-Specific Cell Therapy
by: Xiaojie Wang, et al.
Published: (2012-01-01) -
Advances and Challenges in Islet Transplantation: Islet Procurement Rates and Lessons Learned from Suboptimal Islet Transplantation
by: Annette Plesner, et al.
Published: (2011-01-01) -
Evolution of 𝜷-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation
by: Cyrus Jahansouz, et al.
Published: (2011-01-01) -
Regeneration of Pancreatic β-Islet Cells in a Type-II Diabetic
by: Edwin C. Jones, et al.
Published: (2018-01-01) -
Islet organoids: a new hope for islet transplantation in diabetes
by: Xuemei Yu, et al.
Published: (2025-01-01)